Summary
A spectrophotometric method for porphobilinogen deaminase assay in erythrocytes is described. This test is determinant for the definite diagnosis of acute intermittent porphyria. In the method described, δ-aminolevulinic acid is used as substrate. Mercaptoethanol and zinc ions are introduced to maintain δ-aminolevulinic acid dehydratase in optimal conditions and to guarantee thein vitro production of porphobilinogen. An incubation temperature of 45°C leads to the production of uroporphyrins, which are measured spectrophotometrically at 405 nm, giving reproducible results. The assay can be performed easily in any clinical laboratory and is valuable for detecting both patients and carriers of acute intermittent porphyria.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Battle AMC, Wider de Xifra EA, Stella AM (1978) A simple method for measuring erythrocyte porphobilinogenase and its use in the diagnosis of acute intermittent porphyria.Int J Biochem 9: 871–875.
Brocklehurst D, Wider de Xifra EA, Battle AMC (1980) The measurement of erythrocyte uroporphyrinogen I synthase in the diagnosis of latent and acute intermittent porphyria.Int J Biochem 12: 791–793.
Elder GH (1993) Molecular genetics of disorders of haem biosynthesis.J Clin Pathol 46: 977–981.
Ford RE, Chin-Nan O, Ellefson RD (1981) Liquid chromatographic analysis for urinary porphyrins.Clin Chem 27: 397–401.
Grandchamp B, N'auyen P, Grelier M, Nordmann Y (1976) The spectrophotometric determination of uroporphyrinogen I synthetase activity.Clin Chim Acta 70: 113–118.
Gu XF, de Rooij F, Lee JS et al (1992) High frequency of mutations in exon 10 of the porphobilinogen deaminase gene in patients with a CRIM-positive subtype of acute intermittent porphyria.Am J Hum Genet 51: 660–665.
Gu XF, de Rooij F, Lee JS et al (1993) High prevalence of a point mutation in the porphobilinogen deaminase gene in Dutch patients with acute intermittent porphyria.Hum Genet 91: 128–130.
Hindmarsh JT (1986) The porphyrias: recent advances.Clin Chem 32: 1255–1263.
Kappas A, Sassa S, Galbraith RA, Nordmann Y (1989) The porphyrias. In Scriver CR, Beaudet AL, Sly WS and Valle D, eds.The Metabolic Basis of Inherited Diseases, 6th edn. New York: McGraw-Hill, 1305–1365.
Moore MR (1980) International review of drugs in acute porphyria — 1980.Int J Biochem 12: 1089–1097.
Peterson LR, Hamernik P, Bird TD, Labbe RF (1976) Erythrocyte uroporphyrinogen I synthase activity in diagnosis of acute intermittent porphyria.Clin Chem 22: 1835–1840.
Piepkorn MW, Hamernyk P, Labbe RF (1978) Modified erythrocyte uroporphyrinogen I synthase assay, and its clinical interpretation.Clin Chem 24: 1751–1754.
Straka JG, Rank JM, Bloomer JR (1990) Porphyria and porphyrin metabolism.Annu Rev Med 457–469.
Wigfield D, Farant JP (1979) Factors influencing the pH-activity relationship of delta-aminolevulinic acid dehydratase from human blood, and their relevance to blood lead assay.J Anal Toxicol 3: 161–168.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vázquez-Prado, J., Sánchez-Anzaldo, F.J., Ruiz-Argüelles, G.J. et al. A modified spectrophotometric assay for porphobilinogen deaminase: its application in the detection of both carriers and patients with acute intermittent porphyria. J Inherit Metab Dis 18, 66–71 (1995). https://doi.org/10.1007/BF00711375
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00711375